DK122662B - Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf.Info
- Publication number
- DK122662B DK122662B DK31663AA DK31663A DK122662B DK 122662 B DK122662 B DK 122662B DK 31663A A DK31663A A DK 31663AA DK 31663 A DK31663 A DK 31663A DK 122662 B DK122662 B DK 122662B
- Authority
- DK
- Denmark
- Prior art keywords
- sulfonanilides
- preparation
- acid addition
- therapeutically active
- analogous process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16849862A | 1962-01-24 | 1962-01-24 | |
US24459762A | 1962-12-14 | 1962-12-14 | |
US38550464A | 1964-07-27 | 1964-07-27 | |
US439086A US3341584A (en) | 1962-01-24 | 1965-03-11 | Anilides |
Publications (1)
Publication Number | Publication Date |
---|---|
DK122662B true DK122662B (da) | 1972-03-27 |
Family
ID=27496795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK31663AA DK122662B (da) | 1962-01-24 | 1963-01-23 | Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf. |
Country Status (9)
Country | Link |
---|---|
US (1) | US3341584A (da) |
BR (1) | BR6346374D0 (da) |
CH (1) | CH475962A (da) |
DE (1) | DE1493955B2 (da) |
DK (1) | DK122662B (da) |
FR (4) | FR1599658A (da) |
GB (1) | GB993584A (da) |
NL (1) | NL139523B (da) |
SE (1) | SE334368B (da) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3759993A (en) * | 1971-09-27 | 1973-09-18 | Riker Laboratories Inc | Fluoromethanesulfonic acid derivatives |
US3919424A (en) * | 1972-02-16 | 1975-11-11 | Mead Johnson & Co | Bronchodilator process and composition |
US3993776A (en) * | 1973-10-15 | 1976-11-23 | Mead Johnson & Company | Anorexigenic process and composition |
US3979514A (en) * | 1974-08-26 | 1976-09-07 | Mead Johnson & Company | Process for interrupting pregnancy with sulfonamidoaminophene interceptive agents |
US3968242A (en) * | 1974-08-26 | 1976-07-06 | Mead Johnson & Company | Sulfonamidoaminopropiophenone interceptive process |
GB1482099A (en) * | 1974-12-11 | 1977-08-03 | Wyeth John & Brother Ltd | Sulphonamido derivatives |
US3966770A (en) * | 1975-03-25 | 1976-06-29 | Smithkline Corporation | 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol |
US4044150A (en) * | 1976-06-18 | 1977-08-23 | Mead Johnson & Company | Antihypertensive 4'-[1-hydroxy-2-[(1-phenoxy ethyl)-amino]ethyl]methanesulfonanilide and salts thereof and therapeutic use |
NZ186175A (en) * | 1977-01-27 | 1980-03-05 | Shionogi & Co | Meta-sulphonamidobenzamide derivatives |
GB2077102A (en) * | 1980-06-09 | 1981-12-16 | Bristol Myers Co | Ophthalmic compositions |
US4404224A (en) * | 1981-12-02 | 1983-09-13 | American Cyanamid Company | Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals |
US4618624A (en) * | 1981-12-02 | 1986-10-21 | American Cyanamid Company | 3-amino-4-hydroxy(or alkoxy)phenethanolamine derivatives and pharmacologically-acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm-blooded animals |
FR2541999B1 (fr) * | 1983-03-04 | 1986-09-19 | Bristol Myers Co | Phenethanolamines et leurs utilisations |
US4540581A (en) * | 1984-01-31 | 1985-09-10 | Bristol-Myers Company | Topical nonsteroidal anti-inflammatory compositions and uses |
US5089526A (en) * | 1983-05-23 | 1992-02-18 | Bristol-Myers Company | Antiarrhythmic class III process |
CA1237079A (en) * | 1983-05-23 | 1988-05-24 | Arthur Simon | Antiarrhythmic class iii process |
US4657929A (en) * | 1983-10-25 | 1987-04-14 | Fisons Plc | Compounds |
US4507320A (en) * | 1983-12-07 | 1985-03-26 | Smithkline Beckman Corporation | Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine |
US4574129A (en) * | 1984-01-31 | 1986-03-04 | Bristol-Myers Company | Topical nonsteroidal anti-inflammatory methods |
US5155268A (en) * | 1984-05-04 | 1992-10-13 | The Upjohn Company | Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides |
GB8426200D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
US4920116A (en) * | 1985-06-28 | 1990-04-24 | Schering A.G. | N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4(methylsulfonylamino)benzamides |
GB8603120D0 (en) * | 1986-02-07 | 1986-03-12 | Pfizer Ltd | Anti-dysrhythmia agents |
GB8609331D0 (en) * | 1986-04-16 | 1986-05-21 | Pfizer Ltd | Anti-arrythmia agents |
EG18188A (en) * | 1986-05-01 | 1992-09-30 | Pfizer Ltd | Process for preparation anti-arhythmia agents |
GB8707120D0 (en) * | 1987-03-25 | 1987-04-29 | Pfizer Ltd | Antiarrhythmic agents |
US4857651A (en) * | 1987-07-29 | 1989-08-15 | American Cyanamid Company | α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof |
PH25458A (en) * | 1987-08-24 | 1991-07-01 | Eisai Co Ltd | Piperidine derivatives, therapeutic, preventive agents |
GB8909273D0 (en) * | 1989-04-24 | 1989-06-07 | Glaxo Group Ltd | Chemical compounds |
US5405997A (en) * | 1989-07-25 | 1995-04-11 | The Upjohn Company | Antiarrhythmic methanesulfonamides |
US5360822A (en) * | 1990-02-07 | 1994-11-01 | Nippon Shinyaku Co. Ltd. | Sulfonanilide derivatives and medicine |
HU209251B (en) * | 1992-03-13 | 1994-04-28 | Synepos Ag | Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons |
ES2122038T3 (es) * | 1992-08-26 | 1998-12-16 | Procter & Gamble | Correa para la fabricacion de papel con configuracion semicontinua y papel fabricado sobre ella. |
US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
US5874475A (en) * | 1995-12-21 | 1999-02-23 | Pharmacia & Upjohn Company | Antiarrhythmic (S)-enantiomers of methanesulfonamides |
US5770615A (en) * | 1996-04-04 | 1998-06-23 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
DE10104369A1 (de) * | 2001-02-01 | 2002-08-08 | Boehringer Ingelheim Pharma | Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz |
US6660772B2 (en) | 2001-02-01 | 2003-12-09 | Boehringer Ingelheim Pharma Kg | Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence |
EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
EA009646B1 (ru) | 2003-05-30 | 2008-02-28 | Рэнбакси Лабораториз Лтд. | Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa |
KR20070104942A (ko) * | 2005-02-21 | 2007-10-29 | 론자 아게 | 거울상적으로 순수한 1-치환-3-아미노알코올의 제조 방법 |
AU2006313430B2 (en) | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
EP2119700B1 (en) * | 2007-01-31 | 2012-08-01 | Toray Industries, Inc. | Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
US8198330B2 (en) * | 2008-07-31 | 2012-06-12 | Toray Industries, Inc. | Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
CA2740952C (en) * | 2008-10-22 | 2015-12-29 | Ian L. Scott | Compounds for treating ophthalmic diseases and disorders |
US10793519B2 (en) | 2018-05-02 | 2020-10-06 | Academic Pharmaceuticals Incorporated | Ultra short acting anti-arrhythmic agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH364248A (de) * | 1957-12-24 | 1962-09-15 | Geigy Ag J R | Verfahren zur Herstellung neuer Aminobenzoesäure-Derivate |
-
0
- GB GB993584D patent/GB993584A/en active Active
- FR FR148D patent/FR148F/fr active Active
-
1963
- 1963-01-19 DE DE1963M0055500 patent/DE1493955B2/de active Granted
- 1963-01-23 SE SE00731/63A patent/SE334368B/xx unknown
- 1963-01-23 FR FR1599658D patent/FR1599658A/fr not_active Expired
- 1963-01-23 NL NL63288065A patent/NL139523B/xx not_active IP Right Cessation
- 1963-01-23 BR BR146374/63A patent/BR6346374D0/pt unknown
- 1963-01-23 DK DK31663AA patent/DK122662B/da unknown
- 1963-01-24 CH CH85463A patent/CH475962A/de not_active IP Right Cessation
- 1963-04-22 FR FR932206A patent/FR3027M/fr active Active
-
1965
- 1965-03-11 US US439086A patent/US3341584A/en not_active Expired - Lifetime
- 1965-06-05 FR FR19770A patent/FR95660E/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BR6346374D0 (pt) | 1973-05-24 |
US3341584A (en) | 1967-09-12 |
DE1493955A1 (de) | 1971-08-19 |
DE1493955B2 (de) | 1976-11-18 |
GB993584A (da) | |
CH475962A (de) | 1969-07-31 |
FR1599658A (da) | 1970-07-20 |
SE334368B (da) | 1971-04-26 |
FR95660E (fr) | 1971-04-16 |
FR148F (da) | |
NL139523B (nl) | 1973-08-15 |
FR3027M (fr) | 1964-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK122662B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive sulfonanilider eller syreadditionssalte eller metalsalte deraf. | |
DK109992C (da) | Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf. | |
DK108864C (da) | Fremgangsmåde til fremstilling af (3-aminopyrazinamido)- guanider eller syreadditionssalte deraf. | |
DK133372B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf. | |
DK109037C (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf. | |
DK107357C (da) | Fremgangsmåde til fremstilling af basiske estere eller syreadditionssalte deraf. | |
DK114840B (da) | Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf. | |
DK111564B (da) | Fremgangsmåde til fremstilling af sympathicolytisk virksomme phenoxyalkylguanidiner eller syreadditionssalte heraf. | |
DK104460C (da) | Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf. | |
DK109779C (da) | Fremgangsmåde til fremstilling af 3-aminopyrazinamidoguanidinforbindelser eller syreadditionssalte heraf. | |
DK111894B (da) | Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf. | |
DK115842B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. | |
DK103672C (da) | Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf. | |
DK106908C (da) | Fremgangsmåde til fremstilling af N-(sulfobenzoyl)-N-desulfohepariner eller alkalimetalsalte deraf. | |
DK114964B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme α-substituerede 1-naftylacetamider eller syreadditionssalte deraf. | |
DK118189B (da) | Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf. | |
DK109676C (da) | Fremgangsmåde til fremstilling af primære alkylphenylalkylaminer eller syreadditionssalte deraf. | |
DK104171C (da) | Fremgangsmåde til fremstilling af morfantridinderivater eller syreadditionssalte heraf. | |
DK103077C (da) | Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf. | |
DK106041C (da) | Fremgangsmåde til fremstilling af 1-phenyl-2-alkylaminoalkanolderivater eller syreadditionssalte deraf. | |
DK100427C (da) | Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf. | |
DK100556C (da) | Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf. | |
DK107418C (da) | Fremgangsmåde til fremstilling af phenoxyalkylaminoguanidiner eller syreadditionssalte heraf. | |
DK100557C (da) | Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf. | |
DK107225C (da) | Fremgangsmåde til fremstilling af bis-aralkylaminoalkyl-cyclohexaner eller syreadditionssalte heraf. |